ESR1 and breast carcinoma: The cumulative results showed that the T lymphocyte infiltration of triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2 (HER2) breast cancer was higher than that of estrogen receptor-positive and HER2 negative breast cancer.